A risk of developing chronic kidney disease is more if a person is diagnosed with type 2 diabetes (T2D) and cardiovascular diseases. Researchers say factors associated with chronic kidney disease (CKD) are
Researchers say factors associated with lower chronic kidney disease (CKD) are
The study was funded by Novo Nordisk.
Diabetes Research Institute (DRI) at the University of Miami, developed a new technique to treat type 1 diabetes (T1D). DRI gave treatment for 41 years aged European for the first time. The patient was diagnosed with type 1 diabetes (T1D) at the age of 11 years. The treatment named as BioHub platform is actually a bioengineered mini organ and imitates pancreas to supply insulin in patients with type 1 diabetes (T1D). The mini organ is a biodegradable gel-like material made with patients own blood plasma and thrombin enzyme and it contains implanted donor islets. The gel and islets were then stuck to a tissue layer near the stomach area called omentum. Ospedale Niguarda Ca Granda (Milan, Italy) is the first European hospital to do DRI BioHub procedure.
Medtronic MiniMed insulin pumps and sensors got compatibility with Glooko diabetes management platform. With this compatibility, patients and clinics can download data from Medtronic insulin pumps and CGM sensors and can analyze insulin data. The data from Medtronic products are available through Glooko Mobile App for iOS and Android smartphones.
After studying more than 9,000 children, it was found that children may develop type 1 diabetes (T1D) if the child experience inflammatory arthritis. The study findings suggested further study required to understand the link between arthritis and diabetes in children and how to treat both diseases. The study suggests that type 1 diabetes (T1D) present in the child will not enhance juvenile inflammatory arthritis. Co-author Kirsten Minden was from the Rheumatism Research Center in Berlin, Germany. The study findings were presented in the European League Against Rheumatism Annual Congress (EULAR 2016) held in London between 8 and 11 June, 2016.
The risk of atrial fibrillation (AF), which is associated with risk of mortality, increases in a person if the person
The risk of atrial fibrillation (AF) will decrease with cardiorespiratory fitness. Veterans Affairs Medical Center in Washington, DC examined and conducted routine exercise tests on over 12,000 individuals from 1986 to 2012 and disclosed above findings.
According to M. M. Engelgau, the current methods in the screening of type 2 diabetes (T2D) using fasting metabolic state are not effective. The tests should detect the disease in the pre-clinical stage itself. Researchers followed 2,138 individuals over a period of 33 years and categorized them into four groups. They found that group of patients with 2-hour glucose levels less than 140mg/dL and elevated 1-hour glucose levels have 28% more risk of mortality compared with a group of patients with nonelevated 1-hour or 2-hours glucose levels. If 1-hour prandial glucose levels are more than 155 mg/dL even though 2-hour glucose levels or normal, then one can predict coming of diabetes disease in an individual.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.